FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/04/008289 [Registered on: 03/04/2017] Trial Registered Prospectively
Last Modified On: 27/03/2017
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study to evaluate the efficacy of pectoral nerve block ie to make pectoral nerve numb, as a pain killer in breast cancer patients after their surgery.  
Scientific Title of Study   Randomized controlled study to evaluate the efficacy of pectoral nerve block for post operative analgesia in patients undergoing mastectomy. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kailash S Sharma 
Designation  Professor 
Affiliation  Tata Memorial Hospital 
Address  Dept. of Anaesthesia, Critical Care and Pain, Second floor, Main building, Tata Memorial Hospital, Parel

Mumbai
MAHARASHTRA
400012
India 
Phone  9821161087  
Fax    
Email  rashmikailashsharma@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sudivya Sharma 
Designation  Assistant Professor 
Affiliation  Tata Memorial Hospital 
Address  Dept. of Anaesthesia, Critical Care and Pain, Second floor, Main building, Tata Memorial Hospital, Parel

Mumbai
MAHARASHTRA
400012
India 
Phone  9892762615  
Fax    
Email  drsudivyasharma@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sudivya Sharma 
Designation  Assistant Professor 
Affiliation  Tata Memorial Hospital 
Address  Dept. of Anaesthesia, Critical Care and Pain, Second floor, Main building, Tata Memorial Hospital, Parel

Mumbai
MAHARASHTRA
400012
India 
Phone  9892762615  
Fax    
Email  drsudivyasharma@gmail.com  
 
Source of Monetary or Material Support  
Tata Memorial Hospital Dept. of Anaesthesia, Critical Care and Pain, Second floor, Main building, Tata Memorial Hospital, Parel 
 
Primary Sponsor  
Name  Tata Memorial Hospital 
Address  Dept. of Anaesthesia, Critical Care and Pain, Second floor, Main builing, Tata Memorial Hospital Parel, Mumbai 400012 
Type of Sponsor  Other [Intramural Funding] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kailash Sharma  Tata Memorial Centre  Dept. of Anaesthesia, Critical Care and Pain, Second floor, Main building, Tata Memorial Hospital, Parel 400012
Mumbai
MAHARASHTRA 
9821161087

rashmikailashsharma@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee I  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  ASA I/ ASA II patients posted for unilateral non-reconstructive mastectomy ,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  CONTROL group   This group will directly proceed to surgery 
Intervention  PEC group   This group will receive ipsilateral Pectoral nerve block I & II under ultra sonographic guidance by experienced anaesthesiologist  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. ASA I/ ASA II patients
2. Posted for unilateral non-reconstructivemastectomy.
3. Informed consent
 
 
ExclusionCriteria 
Details  1. Sensitivity to local anaesthetic agent.
2. Bleeding disorders or receiving anticoagulants.
3. Body mass index (BMI) > 35/kg/m2.
4. Pregnancy.
5. Post radiation patients.
6. Patients on other studies which can interfere with the outcome of the study.
7. Patients with deranged liver function test and renal function test.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1. Immediate post operative pain scores at rest and movement after shifting the patient to recovery and then 2 hourly till 6 hours
2. Time to rescue analgesia.  
Post operative pain scores at rest and movement after shifting the patient to recovery and then at 2hrs, 4 hrs and 6 hrs. 
 
Secondary Outcome  
Outcome  TimePoints 
1. Total intraoperative fentanyl consumption
2. Postoperative pain scores at 12, 18 and 24 hours or at discharge whichever is earlier.
3. Post operative nausea vomiting.
4. Patient satisfaction.
5. Complications, if any.
 
Postoperative 12, 18 and 24 hours 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/04/2017 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Background

Breast cancer is now the most common cancer in most cities in India, and the second most common in rural areas. In India, 1,44,937 women were newly detected with breast cancer in year 2012.

As the number of breast cases are increasing; so are increasing the number of surgeries, henceforth incidence of acute pain, conversion of acute pain to chronic pain and breast cancer recurrence. Hence by offering reduction in post operative pain in these patients, the recovery is enhanced, discharge is early, there is decreased associated risk of ileus, thromboembolism, myocardial infarction, immune and pulmonary dysfunction. 

Body’s response to surgical stress causes the release of chemical mediators, which determine up regulation of malignant pathways, disruption of tumor homeostasis and promotion of cancer recurrence.

The options for management of post operative pain in breast surgeries include the use of opioids, non steroidal anti inflammatory drugs (NSAIDS), wound infiltration, thoracic epidural, paravertebral block and Pectoral nerve block.

Study design

This is a Prospective, single blindedRandomized controlled trial to compare pectoral nerve block with control for acute post operative pain management in patients undergoing modified radical mastectomy, to be carried out at Tata Memorial Centre.

Methodology

Informed and written consent would be taken from patients scheduled for modified radical mastectomy, who comply to the inclusion criteria. Demographic data will be recorded and numerical rating pain score (NRS; 0–10, 0 = No Pain, 10= Worst Pain) will be explained to the patients. They will be randomly allocated into two equal groups according to the computer generated sequence.

Patients in both the groups will be given general anaesthesia. In the operation theatre, standard monitors will be attached. Peripheral intravenous access will be secured by 22G cannula. After preoxygenation with 100% oxygen, induction will be done using inj. fentanyl 2 mcg/kg and inj. propofol 2mg/kg and after assessing adequate mask ventilation, non depolarizing neuromuscular blocking agent will be administered.  The airway will be secured by using laryngeal mask airway of appropriate size and anaesthesiamaintained using O2+Air+ Isoflurane.

Group I (PEC group = 30 patients) will receive ipsilateral Pectoral nerve block I & II under ultra sonographic guidance by experienced anaesthesiologist (ie consutant or senior resident who  are trained in regional blocks technique; and junior resident who has performed at least five regional blocks under guidance of senior anesthesiologist)12 post induction,  while the group II (CONTROL group =30 patients) will directly proceed to surgery. Both the groups will receiveInj. Fentanyl 25mcg, if there is intraoperative rise in heart rate &/or blood pressure by 20% above preoperative baseline.All patients will receive injparacetamol 15mg/kg and Inj. Ondansetron at the time of wound closure. No other analgesic except Inj. Fentanyl boluses and single dose of inj. Paracetamol will be given intraoperatively. Total dose of fentanyl givenintraoperatively will be noted. After recovery from anesthesia, patients will be shifted topost-anesthetic care unit (PACU) /recovery where pain will be assessed as explained later.

In the ward, both sets of patients will receiveparacetamol 15mg/ kg 8 hourly (not exceeding 3g/day) and inj. tramadol 50 mg IV as a rescue analgesic i.e. on patient’s demand or if pain score is 4 or more (not exceeding 3 times per day) for first 24 hours or discharge whichever is earlier.

To perform Pectoral nerve block, the patient is positioned supinewith the ipsilateral arm abducted andexternally rotated.Taking complete aseptic precautions, after cleaning and draping the infraclavicular and axillary area,linear ultrasound (US) probe with frequency of 5 -13 hertz is placed at infraclavicular region and moved laterally to locate the axillary artery and vein directly above 2nd rib,along with identification of pectoralis major and pectoralis minor muscles. The skin point of puncture is infiltrated with 2 ml of 2% lignocaine,23 G spinal needle isthen inserted in plane with US probe into the fascial plane and 10 ml of inj. bupivacaine 0.25% is injected between the pectoral muscles. Then, the US probe is moved toward axilla till serratus anterior muscle is identified above 3rd and 4th ribs then the needle is reinserted into the fascial plane between pectoralis minor muscle and serratus anterior muscle and 20 ml of inj. bupivacaine 0.25% is injected.

 

Assessment of outcome

Assessment in recovery room will be done by recovery room anesthesiologist and in wards by Acute pain service ( APS ) team. Pain scores will be noted at rest as well as movement after shifting the patient to recovery denoted as time zero. Subsequently, pain scores will be noted at 2,4,6,12,18,24 hours or discharge whichever is earlier.Also, the pain scores and time when rescue analgesia is demanded will be noted.

Nausea and vomiting will be measured as yes (Y) or no (N) at above times. Nausea and vomiting will be treated with IV antiemetics.

Patient Satisfaction will be measured as poor=0, fair = 1, good =2, excellent = 3, at 24 hours post operative or at discharge, whichever is earlier.

 

Data Analysis

Demographical data and Scales computed for each domain score will be presented as mean (Standard Deviation), median, range and percentage. Categorical data will be analyzed using the chi-square test or Fishers Exact test (for binary data). Comparisons of pain scores for the first 24 hours ( at 0,2,4,6,12,18 and 24hours) of the two  groups will be analyzed using the Independent sample t test or  Mann-Whitney U  test as per the distribution of data. P-value < 0.05 will be considered statistical significant.

 

Sample Size:

Calculation of sample size based on a preliminary observational study involving 24patients undergoing unilateral non reconstructive mastectomies in Tata MemorialCentre in which, mean pain scores in the immediate post-operative period were assessed.The mean postoperative pain score was found to be 6.5/10 on movement according toNumerical Rating Scale, which is moderate to severe pain (0-No pain, 1-3 mild pain, 4-6 moderate pain, 7-10 severe pain). Assuming that a reduction of score by 30%, (i.e, areduction by 2 units on the numerical rating scale would convert this pain from themoderate range to the mild range) will be significant, a value of 30 patients in each ofthe 2 groups was calculated.

Aims and Objective

Aim

To evaluate the efficacy of Pectoral Nerve Block for post operative analgesia in breast surgery patients.

 
Close